Nomenclature of systemic vasculitides

JC Jennette, RJ Falk, K Andrassy… - … : Official Journal of …, 1994 - Wiley Online Library
In spite of substantial efforts by many investigators as well as numerous publications on the
subject, the nomenclature of the systemic vasculitides remains enigmatic. A major problem …

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

B Hellmich, O Flossmann, WL Gross, P Bacon… - Annals of the …, 2007 - ard.bmj.com
Objectives: To develop the European League Against Rheumatism (EULAR)
recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis …

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic …

C Mukhtyar, O Flossmann, B Hellmich… - Annals of the …, 2008 - ard.bmj.com
Objectives: We undertook a systematic literature review as a background to the European
League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti …

Netting neutrophils in autoimmune small-vessel vasculitis

K Kessenbrock, M Krumbholz, U Schönermarck… - Nature medicine, 2009 - nature.com
Small-vessel vasculitis (SVV) is a chronic autoinflammatory condition linked to antineutrophil
cytoplasm autoantibodies (ANCAs). Here we show that chromatin fibers, so-called …

[HTML][HTML] Genetically distinct subsets within ANCA-associated vasculitis

PA Lyons, TF Rayner, S Trivedi, JU Holle… - … England Journal of …, 2012 - Mass Medical Soc
Background Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe
condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly …

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial

K De Groot, L Harper, DRW Jayne… - Annals of internal …, 2009 - acpjournals.org
Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)–associated
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

K De Groot, N Rasmussen, PA Bacon… - … : Official Journal of …, 2005 - Wiley Online Library
Objective Standard therapy for antineutrophil cytoplasmic antibody–associated systemic
vasculitis (AASV) with cyclophosphamide (CYC) and prednisolone is limited by toxicity. This …

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long‐term outcome in 155 patients

E Reinhold‐Keller, N Beuge, U Latza… - … : Official Journal of …, 2000 - Wiley Online Library
Objective To examine the outcome in 155 consecutive patients with Wegener's
granulomatosis (WG) followed up for a median of 7 years. Methods Treatment was adapted …

Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis

B Nolle, U Specks, J Lüdemann… - Annals of Internal …, 1989 - acpjournals.org
Abstract Study Objective: To determine disease specificity and sensitivity of anticytoplasmic
autoantibodies (ACPA) for Wegener granulomatosis, as well as their value as a marker of …

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis

RJ Falk, WL Gross, L Guillevin, G Hoffman… - Annals of the …, 2011 - ard.bmj.com
The Boards of Directors of the American College of Rheumatology (ACR), American Society
of Nephrology (ASN) and the European League Against Rheumatism (EULAR) have …